Moreover, El1405 intervention significantly increased the levels of TNF-α, INF-γ, and CD8 in the tumor microenvironment, while decreasing the levels of CD4, IL-6, IL-10, and TGF-β. The gene discussed is CD8A; the disease is neoplasm.